Scarica l'app Stockscreener
23.21
1.69%
-0.40
Precedente Chiudi:
$23.61
Aprire:
$23.46
Volume 24 ore:
739.93K
Relative Volume:
0.66
Capitalizzazione di mercato:
$1.92B
Reddito:
$1.13B
Utile/perdita netta:
$62.75M
Rapporto P/E:
36.84
EPS:
0.63
Flusso di cassa netto:
$170.92M
1 W Prestazione:
+8.15%
1M Prestazione:
+7.01%
6M Prestazione:
+23.72%
1 anno Prestazione:
-17.64%
Intervallo 1D:
$23.05
$23.60
Intervallo di 1 settimana:
$21.20
$24.66
Portata 52W:
$13.39
$30.42
Progyny Inc Stock (PGNY) Company Profile
Nome
Progyny Inc
Settore
Industria
Telefono
212-888-3124
Indirizzo
1359 BROADWAY, NEW YORK, NY
Confronta PGNY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
23.21 | 1.92B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
304.10 | 275.58B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
340.67 | 86.74B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
303.27 | 82.87B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
64.78 | 81.29B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
230.67 | 28.00B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Downgrade | Truist | Buy → Hold |
| 2024-09-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-08-07 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-05-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-09-27 | Iniziato | Canaccord Genuity | Buy |
| 2023-05-22 | Iniziato | BTIG Research | Buy |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Iniziato | Truist | Buy |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-22 | Downgrade | Citigroup | Buy → Neutral |
| 2021-09-30 | Iniziato | Berenberg | Buy |
| 2021-08-12 | Iniziato | Barclays | Overweight |
| 2021-06-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-04-29 | Ripresa | JP Morgan | Overweight |
| 2021-03-10 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-02 | Iniziato | Guggenheim | Buy |
| 2019-11-19 | Iniziato | Citigroup | Buy |
| 2019-11-19 | Iniziato | Goldman | Buy |
| 2019-11-19 | Iniziato | JP Morgan | Overweight |
| 2019-11-19 | Iniziato | Piper Jaffray | Overweight |
| 2019-11-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Progyny Inc Borsa (PGNY) Ultime notizie
Progyny and Oura: A Wearable Tech Revolution in Women's Health and Its Implications for Investors - AInvest
Progyny partners with Oura for women’s health monitoring By Investing.com - Investing.com South Africa
Progyny, Inc. Partners with ŌURA to Enhance Women's Health Insights Through Wearable Technology - Quiver Quantitative
Progyny Partners with ŌURA to Empower Women and Their Care - GlobeNewswire
Progyny Partners Oura Ring: Game-Changing Data Integration Reshapes Fertility Care - Stock Titan
Progyny rises on guidance update - MSN
Progyny upgraded to Outperform at Leerink after positive pre-announcement - MSN
Progyny Inc Stock (PGNY): Strong Growth Post Q1 Results - Value The Markets
Strength Seen in Progyny (PGNY): Can Its 13.2% Jump Turn into More Strength? - Nasdaq
Progyny (PGNY) Receives Rating Upgrade from Leerink Partners | P - GuruFocus
Progyny stock gains as BTIG reiterates Buy rating on favorable Q2 outlook - Investing.com Nigeria
Under the Radar: Hunting Smart in the Alleyway of Value and Growth - Benzinga
Progyny stock (PGNY) rises: what’s going on with Progyny Inc? - Markets.com
Progyny Expects Q2 Results 'Slightly Above' Guidance, Enters $200 Million Revolver; Shares Rise - MarketScreener
Progyny stock rises on guidance update (PGNY:NASDAQ) - Seeking Alpha
Progyny Reveals $200 Mln Revolving Credit Facility, Sees Q2 Results Slightly Ahead Of Expectations - Nasdaq
Progyny, Inc. Enters into A Revolving Credit Facility - MarketScreener
Progyny Secures $200M Credit Facility with JPMorgan - TipRanks
Progyny secures $200 million revolving credit facility, expects Q2 results above guidance - Investing.com
Progyny, Inc. Secures $200 Million Credit Facility to Enhance Financial Flexibility and Anticipates Positive Second Quarter Results - Nasdaq
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report | PGNY Stock News - GuruFocus
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report - The Manila Times
Progyny Boosts Financial Muscle with $200M Credit Line as Q2 Results Set to Beat Expectations - Stock Titan
(PGNY) Proactive Strategies - news.stocktradersdaily.com
Progyny’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Here’s Why Progyny (PGNY) Rebounded in Q1 - Insider Monkey
Progyny (PGNY) Expands Women's Health Benefits with New Partners - GuruFocus
Progyny Expands Women's Health Offerings with New Pelvic Floor Therapy Services - Nasdaq
One-Third of Women Need It: Progyny Unveils Game-Changing Pelvic Health Solution with Digital Therapy - Stock Titan
(PGNY) Investment Analysis - news.stocktradersdaily.com
Progyny (PGNY) Soared on Expanding Client Base and Improving Utilization Trends - Insider Monkey
Progyny director Scott Cheryl sells $59,037 in stock By Investing.com - Investing.com Canada
Progyny director Scott Cheryl sells $59,037 in stock - Investing.com Australia
Insider Sell: Cheryl Scott Sells Shares of Progyny Inc (PGNY) - GuruFocus
Progyny Stock Trades Higher On Collaboration With Amazon’s Health Benefits Connector: Retail’s Yet To Be Impressed - Asianet Newsable
Progyny (PGNY) and Amazon Team Up to Enhance Women's Health Serv - GuruFocus
Progyny Joins Amazon's Health Benefits Connector Program as Firs - GuruFocus
Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution | PGNY Stock News - GuruFocus
Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution - GlobeNewswire
Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution - The Manila Times
Breakthrough Partnership: Amazon Picks Progyny as Exclusive Women's Health Provider for 6.7M Lives - Stock Titan
(PGNY) On The My Stocks Page - news.stocktradersdaily.com
Progyny, Inc. (NASDAQ:PGNY) Stake Reduced by California State Teachers Retirement System - Defense World
Progyny, Inc. (PGNY) Stock Analysis: Uncovering a 20.97% Upside Potential in Healthcare Plans - DirectorsTalk Interviews
Progyny, Inc. (NASDAQ:PGNY) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Progyny, Inc. (NASDAQ:PGNY) Shares Purchased by Nuveen Asset Management LLC - Defense World
Progyny appoints Elizabeth Bierbower to board By Investing.com - Investing.com South Africa
Progyny (PGNY) Welcomes Elizabeth Bierbower to Its Board of Dire - GuruFocus
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbo - GuruFocus
Progyny appoints Elizabeth Bierbower to board - Investing.com Australia
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors | PGNY Stock News - GuruFocus
Progyny Inc Azioni (PGNY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):